Astera Labs
$350.33Change from previous close: −1.71%Absolute change: −$6.09
At a glance
- Revenue growth
- +115.13%
- 2025 vs 2024
- Net margin
- 25.7%
- 2024: -21.1%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 87.7 | 74.6 | 95.3 | 78.2 | 135 | 10.5 | 39.7 | 63.5 | 29.8 | 3.7 | 14.4 | -0.3 |
| Depreciation and amortization | 3.9 | 3.7 | 2.8 | 1.5 | 1.4 | 1.1 | 1.0 | 0.8 | 0.7 | 0.6 | 0.5 | 0.5 |
| Capital expenditure | -20.5 | -7.6 | -18.7 | -12.3 | -2.0 | -4.5 | -15.4 | -16.7 | 1.3 | -3.4 | -1.0 | -0.7 |
| Investing cash flow | -132 | -94.0 | -72.8 | -101 | -63.7 | -3.9 | -91.4 | -359 | -302 | -4.3 | -6.0 | -56.3 |
| Financing cash flow | 7.0 | 0.1 | 3.7 | 1.0 | 4.7 | 0.4 | 5.7 | 1.0 | -2.3 | 652 | -1.1 | 0.6 |
| Share repurchases | — | — | — | — | — | — | -1.1 | — | — | -20.1 | -0.2 | — |
| Net change in cash | -36.8 | -19.3 | 26.2 | -21.9 | 76.4 | 7.0 | -46.1 | -295 | -275 | 651 | 7.4 | -56.0 |
| Free cash flow | 67.2 | 67.0 | 76.6 | 65.9 | 133 | 6.0 | 24.3 | 46.8 | 31.1 | 0.2 | 13.4 | -1.1 |
| Levered free cash flow | -28.5 | 18.9 | 82.3 | 19.3 | 120 | -14.3 | -8.8 | 51.7 | 41.4 | 36.9 | — | — |